Your session is about to expire
← Back to Search
Text Message Reminders for Breast Cancer Medication Adherence
Study Summary
This trial is testing whether text reminders can help people remember to take their cancer medication.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 or older and starting treatment with Ibrance for breast cancer.I am starting Ibrance for the first time, alone or with Femara or Faslodex.Patients who do not have someone to help manage their healthcare.I have taken the medication Ibrance.I can send and receive texts using the study app.
- Group 1: Standard of Care
- Group 2: Standard of Care + Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what regions can participants access this research trial?
"As of now, there are 7 clinical trial sites open for recruitment. These include Memorial Sloan Kettering Nassau (Limited Protocol Activities) in Rockville Centre, Memorial Sloan Kettering Commack (Limited Protocol Activities) in Commack, and Memorial Sloan Kettering Monmouth (Limited Protocol Activities) in Middletown. There is also a selection of other medical centres accepting patients."
How many participants are engaged in this clinical investigation?
"Absolutely. According to the information provided on clinicaltrials.gov, this research program was first advertised in December of 2019 and has since been updated in July 2022. Currently, 100 participants are sought from seven distinct medical centres."
Is the patient enrollment for this experiment still open?
"As evidenced by clinicaltrials.gov, this trial is still seeking participants; it was initially published on December 27th 2019 and last revised on July 28th 2022."
Share this study with friends
Copy Link
Messenger